You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
Astellas was recognized in Seramount’s 2021 Top 75 Companies for Executive Women list.
Seramount announced its annual list of the 2021 Top 75 Companies for Executive Women and has included Astellas for the first time. The Top Companies for Executive Women list evaluates companies on every aspect of women’s advancement, including succession planning, profit-and-loss roles, gender pay parity, support programs and work-life balance programs. Its examination of policies, programs and leadership demographics of participating companies yields the most definitive list of top workplaces for women who want to advance to the most senior levels.
“We are proud to be recognized as a Top Company for Executive Women,” said La Toya McClellan, senior director, Engagement, Diversity and Inclusion. “Currently, 45% of our company’s executive roles (senior director and above) in the US region are held by women. Being on this list demonstrates that our programs are making progress in providing women with the opportunities they need to grow, be successful, and contribute value at Astellas.”
Astellas empowers women’s advancement through various programs, development opportunities, and benefits including caregiving support to help working parents and elderly care of aging parents allowing our employees to thrive in the workplace.
Our Stellar Women Employee Impact Group (SWEIG) of more than 900 members meets, discusses and implements ideas to help create an environment of empowerment and advocacy to advance and inspire women at Astellas.
Examples of SWEIG programs include:
Our comprehensive StarLife benefits program offers employees flexibility in how and where employees do their work, robust leave programs to support growing families, and a full spectrum of caregiving support for employees and their extended families. Additional programs to support flexible scheduling include half day Fridays year-round and volunteer time off. Also our Human Resources department conducts strategy succession planning for leadership roles to ensure continuity within the organization and for employees.
Astellas is dedicated to continued exploration and enhancement of innovative benefits and programs that support women at all levels to succeed and is also recognized as a top workplace for Working Mothers and Dads.
Seramount, now part of EAB, is a strategic professional services firm dedicated to advancing diversity, equity, and inclusion in the workplace. Over four decades, partnering with some of the most iconic companies in the world, we’ve built a deep, data-driven understanding of the employee experience, which lays the groundwork for everything we do. Our comprehensive DE&I toolkit includes actionable research and insights, membership, strategic guidance and consulting, and inspiring events, meeting each client’s needs no matter where they are on their journey and guiding them along an ever-changing landscape. Seramount has empowered over 450 organizations to realize the business benefits of diversity, equity, and inclusion. Learn more at seramount.com.
Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world. For more information on Astellas, please visit: https://www.astellas.com/us You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma-us.
Get only the email alerts you want.
For media inquiries and reporter requests, please click here to fill out a request form.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.